Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination.
about
Global analysis of outer membrane proteins from Leptospira interrogans serovar Lai.Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogenDiscovery of Novel Leptospirosis Vaccine Candidates Using Reverse and Structural Vaccinology.In silico and microarray-based genomic approaches to identifying potential vaccine candidates against Leptospira interrogans.Calcium binding to leptospira outer membrane antigen LipL32 is not necessary for its interaction with plasma fibronectin, collagen type IV, and plasminogenHost-inducible immunogenic sphingomyelinase-like protein, Lk73.5, of Leptospira interrogans.Genetic diversity among major endemic strains of Leptospira interrogans in China.Genetic diversity of the Leptospiral immunoglobulin-like (Lig) genes in pathogenic Leptospira spp.In vitro identification of novel plasminogen-binding receptors of the pathogen Leptospira interrogansProtection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1.Surfaceome of Leptospira spp.A LigA three-domain region protects hamsters from lethal infection by Leptospira interrogans.Characterization of virulence of Leptospira isolates in a hamster model.LipL21 is a novel surface-exposed lipoprotein of pathogenic Leptospira speciesClostridium perfringens antigens recognized by broiler chickens immune to necrotic enteritisSubunit approach to evaluation of the immune protective potential of leptospiral antigensAnalysis of multiple Leptospira interrogans serovar Canicola vaccine proteomes and identification of LipL32 as a biomarker for potency.Outer membrane proteins of pathogenic spirochetes.Protection against lethal leptospirosis after vaccination with LipL32 coupled or coadministered with the B subunit of Escherichia coli heat-labile enterotoxinThe terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis.Immunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45LigB subunit vaccine confers sterile immunity against challenge in the hamster model of leptospirosis.Leptospirosis vaccines.In LipL32, the major leptospiral lipoprotein, the C terminus is the primary immunogenic domain and mediates interaction with collagen IV and plasma fibronectin.Major surface protein LipL32 is not required for either acute or chronic infection with Leptospira interrogansLipL46 is a novel surface-exposed lipoprotein expressed during leptospiral dissemination in the mammalian host.Molecular evolution and mosaicism of leptospiral outer membrane proteins involves horizontal DNA transfer.Reverse Vaccinology: An Approach for Identifying Leptospiral Vaccine Candidates.A Universal Vaccine against Leptospirosis: Are We Going in the Right Direction?Pathogenic, diagnostic and vaccine potential of leptospiral outer membrane proteins (OMPs).Recombinant vaccines against leptospirosis.Evaluation of immunoprotective activity of six leptospiral proteins in the hamster model of leptospirosis.'Spotted Nanoflowers': Gold-seeded Zinc Oxide Nanohybrid for Selective Bio-captureProtective Immunity and Reduced Renal Colonization Induced by Vaccines Containing Recombinant Leptospira interrogans Outer Membrane Proteins and Flagellin Adjuvant.Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection.Leptospiral membrane proteins--variations on a theme?Increased immunogenicity to LipL32 of Leptospira interrogans when expressed as a fusion protein with the cholera toxin B subunit.Crystallization and preliminary X-ray analysis of LipL32 from Leptospira interrogans serovar Copenhageni.Recombinant OmpL1 protein as a diagnostic antigen for the detection of canine leptospirosis.Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis.
P2860
Q24537234-ADE5ED0C-0383-47BE-BD1D-83927B2C8E64Q24597151-5155AC5E-5701-4FD1-B173-154D732E07B9Q30061569-A6A06FF0-55F6-415D-816A-71E2EA32C151Q30159564-DEC9F2D7-DB0A-41D3-8366-425833565698Q30410349-13394A8C-1A13-46C4-A6C2-3C63DD4B3895Q31037865-E9304334-16EE-4E31-83C1-D3DB530EBAC3Q33289549-820C6D53-8EEE-43D9-BFCF-EA83EF52FF49Q33616781-6A490450-958C-4242-8106-200AB7266907Q33617807-9B966376-4DAA-4731-B400-D6CE5F7030C7Q33883383-4DA90665-F708-4A14-9BC9-98387FA405E7Q33946607-F33F6B04-21A9-4D00-9D85-4A3E1FF6202DQ34105270-633259BF-D8D4-4861-92AD-44266A41B569Q34786061-070FE098-7F32-4E11-B7C5-CE5C1AD25A85Q34936350-E1D1B2FA-0C11-4149-B4DE-9DD8C06828C6Q35216109-2B462D35-CE8A-4B1A-9C3B-1CB010376079Q35598213-6420F57E-566D-4D7B-8E51-2AEAC194B8EDQ35867235-69243582-40C2-43F7-847E-1260DC4D4489Q35902245-8E92A037-C1D5-44D6-8A0D-8E6C5B713E35Q35940659-0B8F6C8A-505A-490C-9519-1CB5E015EB20Q36013519-5D1D3C78-2C34-4BBF-A99F-927625F79452Q36256428-F3785A08-69F5-47DB-A21C-C5161B28C84DQ36310414-34E96233-F747-4E4E-A9D2-E1E10D2BECEBQ36440093-306E46E0-A9CE-42DD-9D0C-A800E6701776Q36710705-0194641F-7FB3-4E4F-81BF-FFD12DA6DD6EQ37099412-C9AE79C1-7707-461A-8E43-0327B2627E5AQ37154107-17A77E97-18D3-40F9-A38E-B55869BCD560Q37425517-EDBBFC65-A696-4B02-A05C-C1A8ACDADE80Q37631622-6CFB565B-2656-4458-98EA-933148F21CB7Q37690431-0CF988EB-3590-49CB-9378-AE6DE7E65974Q38108014-7593F51F-E86E-4290-BA79-AD79AAAFD9B9Q40005348-04B57724-229A-456E-B8CF-3A14E7E84C41Q41630255-1AECFBC7-BF66-4088-8D5B-A5B62B596E86Q41706297-EDB36026-42C7-4F38-A69A-95BD3D3CA09EQ41822782-1CE0C10B-A00C-4135-865D-C742C2B2A2C1Q42118872-3D1BB715-3A79-4B57-90F5-531CB6B93318Q42263349-377A4E44-E664-482D-A8D9-831F802B7183Q42672577-AE99E684-941B-4907-9A7E-D13CE5E43A1CQ43169997-901170F7-AFAC-487D-AA87-4BD60971162AQ46068134-C956BE48-9C49-4EEC-B1BF-50349A8EC9F9Q54438541-63AFED65-330B-4873-8CF9-D57F30FDB84F
P2860
Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Identification of the hemolysi ...... enovirus-mediated vaccination.
@en
Identification of the hemolysi ...... enovirus-mediated vaccination.
@nl
type
label
Identification of the hemolysi ...... enovirus-mediated vaccination.
@en
Identification of the hemolysi ...... enovirus-mediated vaccination.
@nl
prefLabel
Identification of the hemolysi ...... enovirus-mediated vaccination.
@en
Identification of the hemolysi ...... enovirus-mediated vaccination.
@nl
P2093
P2860
P1476
Identification of the hemolysi ...... enovirus-mediated vaccination.
@en
P2093
André-Fontaine G
Chatrenet B
Klonjkowski B
Ruvoen-Clouet N
P2860
P304
P356
10.1128/IAI.69.11.6831-6838.2001
P407
P577
2001-11-01T00:00:00Z